US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
WO1994003159A1
(en)
*
|
1992-07-31 |
1994-02-17 |
Daratech Pty. Ltd. |
Controlled release implants
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
NZ260408A
(en)
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
US5773025A
(en)
*
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
US5662933A
(en)
*
|
1993-09-09 |
1997-09-02 |
Edward Mendell Co., Inc. |
Controlled release formulation (albuterol)
|
US6726930B1
(en)
*
|
1993-09-09 |
2004-04-27 |
Penwest Pharmaceuticals Co. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US5455046A
(en)
*
|
1993-09-09 |
1995-10-03 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
KR100354702B1
(ko)
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5891471A
(en)
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
US5843480A
(en)
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
US5670163A
(en)
*
|
1994-06-20 |
1997-09-23 |
Kv Pharmaceuticals Company |
Long acting GI and esophageal protectant
|
US5554379A
(en)
*
|
1994-06-20 |
1996-09-10 |
Kv Pharmaceutical Company |
Long acting GI and esophageal protectant
|
US5554380A
(en)
*
|
1994-08-04 |
1996-09-10 |
Kv Pharmaceutical Company |
Bioadhesive pharmaceutical delivery system
|
KR960016882A
(ko)
*
|
1994-11-01 |
1996-06-17 |
강재헌 |
치주염치료를 위한 서방출형 생분해성 제제
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
KR970064596A
(ko)
*
|
1996-03-21 |
1997-10-13 |
이우용 |
직장투여용 치질치료제 조성물
|
GB9710767D0
(en)
*
|
1996-06-26 |
1997-07-23 |
On Ninh |
Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
|
US6093420A
(en)
|
1996-07-08 |
2000-07-25 |
Edward Mendell Co., Inc. |
Sustained release matrix for high-dose insoluble drugs
|
US6656508B2
(en)
*
|
1997-04-17 |
2003-12-02 |
Amgen Inc. |
Sustained-release alginate gels
|
US5989571A
(en)
*
|
1997-07-23 |
1999-11-23 |
Millenium Pharmaceutical Technologies, Inc. |
Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
|
US6056977A
(en)
*
|
1997-10-15 |
2000-05-02 |
Edward Mendell Co., Inc. |
Once-a-day controlled release sulfonylurea formulation
|
HU1500214D0
(hu)
|
1997-12-22 |
2002-03-28 |
Euro Celtique Sa |
Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény
|
JP2001526229A
(ja)
*
|
1997-12-22 |
2001-12-18 |
ユーロ−セルティーク,エス.エイ. |
オピオイド投薬剤形の乱用を防止する方法
|
US7022683B1
(en)
*
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
GB9816899D0
(en)
|
1998-08-05 |
1998-09-30 |
Boots Co Plc |
Therapeutic agents
|
ATE310531T1
(de)
|
1998-08-07 |
2005-12-15 |
|
Stabilisierte pharmazeutische zusammensetzungen von hedgehog-proteinen und deren verwendung
|
US6200590B1
(en)
|
1998-08-10 |
2001-03-13 |
Naphcare, Inc. |
Controlled, phased-release suppository and its method of production
|
US6368625B1
(en)
|
1998-08-12 |
2002-04-09 |
Cima Labs Inc. |
Orally disintegrable tablet forming a viscous slurry
|
CA2346001C
(en)
*
|
1998-10-01 |
2003-12-30 |
Elan Pharma International, Limited |
Controlled release nanoparticulate compositions
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
US6225343B1
(en)
*
|
1999-06-16 |
2001-05-01 |
Nastech Pharmaceutical Company, Inc. |
Compositions and methods comprising morphine gluconate
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
JP3893058B2
(ja)
*
|
1999-09-30 |
2007-03-14 |
ペンウェスト ファーマシューティカルズ カンパニー |
高度に可溶性の薬物のための徐放性マトリックス系
|
OA12215A
(en)
|
2000-02-08 |
2006-05-09 |
Euro Celtique Sa |
Tamper-resistant oral opioid agonist formulations.
|
PL357158A1
(en)
|
2000-02-08 |
2004-07-12 |
Euro-Celtique, S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
US20050214327A1
(en)
*
|
2000-06-02 |
2005-09-29 |
Allergan, Inc. |
Neurotoxin-containing suppositories and related methods
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
US20020044962A1
(en)
*
|
2000-06-06 |
2002-04-18 |
Cherukuri S. Rao |
Encapsulation products for controlled or extended release
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
US6777000B2
(en)
*
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
US6720356B2
(en)
*
|
2001-04-20 |
2004-04-13 |
Spencer Feldman |
Magnesium di-potassium EDTA complex and method of administration
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
ES2361148T3
(es)
|
2001-05-11 |
2011-06-14 |
Endo Pharmaceuticals Inc. |
Forma de dosificación de opioides de liberación controlada resistente al abuso.
|
WO2003004031A1
(en)
*
|
2001-07-06 |
2003-01-16 |
Endo Pharmaceuticals, Inc. |
Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
|
DE60230632D1
(de)
*
|
2001-07-18 |
2009-02-12 |
Euro Celtique Sa |
Pharmazeutische kombinationen von oxycodon und naloxon
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
AU2002324624A1
(en)
*
|
2001-08-06 |
2003-02-24 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
IS7142A
(is)
|
2001-08-06 |
2004-02-05 |
Euroceltique S.A. |
Lyfjasamsetningar, sem innihalda morfíngerandaefni, ásamt losanlegu en hömdu mótlyfi
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
ATE371442T1
(de)
*
|
2001-10-12 |
2007-09-15 |
Elan Pharma Int Ltd |
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
US6585996B1
(en)
|
2002-03-13 |
2003-07-01 |
Westlake Laboratories, Inc. |
Lipid-soluble thiamine derivatives in the treatment of autism
|
EP2425823A1
(de)
|
2002-04-05 |
2012-03-07 |
Euro-Celtique S.A. |
Pharmazeutische Zubereitung mit Oxycodon und Naloxon
|
US20050020613A1
(en)
*
|
2002-09-20 |
2005-01-27 |
Alpharma, Inc. |
Sustained release opioid formulations and method of use
|
EP1551372B8
(de)
*
|
2002-09-20 |
2018-08-01 |
Alpharma Pharmaceuticals LLC |
Sequestrier-untereinheit und relevante zusammensetzungen und verfahren
|
AU2003297561A1
(en)
*
|
2002-11-26 |
2004-06-18 |
Garry R. Hollenbeck |
Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
WO2005020933A2
(en)
*
|
2003-09-02 |
2005-03-10 |
University Of South Florida |
Nanoparticles for drug-delivery
|
CA2539027C
(en)
|
2003-09-25 |
2010-02-23 |
Euro-Celtique S.A. |
Pharmaceutical combinations of hydrocodone and naltrexone
|
PL1663229T3
(pl)
|
2003-09-25 |
2010-09-30 |
Euro Celtique Sa |
Farmaceutyczne kombinacje hydrokodonu i naltreksonu
|
TWI483944B
(zh)
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
EP1604666A1
(de)
*
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
|
LT1765292T
(lt)
|
2004-06-12 |
2018-01-10 |
Collegium Pharmaceutical, Inc. |
Nuo piktnaudžiavimo apsaugotos vaistų formos
|
US9308164B2
(en)
*
|
2004-06-30 |
2016-04-12 |
Sovereign Pharmaceuticals, Llc |
Hyoscyamine dosage form
|
EP1702558A1
(de)
*
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Verfahren und Vorrichtung zur Darmtätigkeitserfassung
|
US20070082050A1
(en)
*
|
2005-05-31 |
2007-04-12 |
Cherukuri S R |
Modified release formulations of antihypertensive drugs
|
KR100730321B1
(ko)
|
2005-09-30 |
2007-06-19 |
한국콜마 주식회사 |
패치형태의 리프팅용 2제형 화장료 조성물과 이의 제조방법및 사용방법
|
SE530184C2
(sv)
*
|
2005-12-23 |
2008-03-18 |
Kjell Stenberg |
Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
|
KR20130100029A
(ko)
*
|
2005-12-30 |
2013-09-06 |
모르 리서치 애플리케이션즈 리미티드 |
항문 괄약근을 치료하기 위한 장치
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
US20070286884A1
(en)
*
|
2006-06-13 |
2007-12-13 |
Xylos Corporation |
Implantable microbial cellulose materials for hard tissue repair and regeneration
|
EP2526932B1
(de)
|
2006-06-19 |
2017-06-07 |
Alpharma Pharmaceuticals LLC |
Pharmazeutische Zusammensetzung
|
EP2049087A2
(de)
*
|
2006-07-21 |
2009-04-22 |
LAB International SRL |
Hydrophiles missbrauchssicheres ausgabesystem
|
GB0624880D0
(en)
*
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
US20100266645A1
(en)
*
|
2007-12-17 |
2010-10-21 |
Alfred Liang |
Pharmaceutical compositions
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
EP2317991B1
(de)
*
|
2008-07-07 |
2017-05-03 |
Euro-Celtique S.A. |
Verwendung von opioid-antagonisten zur behandlung von harnverhalt
|
DK2349250T3
(en)
*
|
2008-10-31 |
2017-07-03 |
Lipid Pharmaceuticals Ehf |
Fatty acids for use as a medicament
|
MX347106B
(es)
|
2009-03-10 |
2017-04-12 |
Euro-Celtique S A * |
Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
|
EP2445481B1
(de)
|
2009-06-18 |
2017-03-22 |
Rdd Pharma Ltd. |
Verfahren und vorrichtungen zur freisetzung von arzneimitteln in körperöffnungen
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
CA2803006A1
(en)
|
2010-06-30 |
2012-01-26 |
Victoria Link Ltd. |
Methods and compositions for treatment of multiple sclerosis
|
WO2012085656A2
(en)
|
2010-12-22 |
2012-06-28 |
Purdue Pharma L.P. |
Encased tamper resistant controlled release dosage forms
|
KR20140075807A
(ko)
|
2010-12-23 |
2014-06-19 |
퍼듀 퍼머 엘피 |
탬퍼 저항성 고체 경구 투여 형태
|
AR092858A1
(es)
|
2012-07-16 |
2015-05-06 |
Rhodes Tech |
Procedimiento para una sintesis mejorada de opioide
|
AR091779A1
(es)
|
2012-07-16 |
2015-02-25 |
Rhodes Technologies |
Procedimiento para la sintesis mejorada de opioides
|
CN102823585B
(zh)
*
|
2012-08-28 |
2014-06-25 |
中国农业科学院农业环境与可持续发展研究所 |
一种水溶性农药缓控释制剂及其制备方法
|
MX2015010041A
(es)
|
2013-02-05 |
2015-10-30 |
Purdue Pharma Lp |
Formulacion farmaceuticas resistentes a la alteracion.
|
WO2014140899A2
(en)
|
2013-03-15 |
2014-09-18 |
Johnson Matthey Public Limited Company |
Morphine sulfate methanolic solvate, processes for making same and related compositions and methods for treating pain
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
CN105517551A
(zh)
|
2013-07-23 |
2016-04-20 |
欧洲凯尔特公司 |
用于在患有疼痛和导致肠生态失调和/或提高肠细菌移位风险之疾病的患者中治疗疼痛的羟考酮与纳洛酮的组合
|
CN105452253A
(zh)
|
2013-08-02 |
2016-03-30 |
庄信万丰股份有限公司 |
用于制备氢羟吗啡酮的方法
|
US20170000727A1
(en)
*
|
2013-12-20 |
2017-01-05 |
Disphar International B.V. |
Dry enema product
|
JP2017502991A
(ja)
|
2014-01-15 |
2017-01-26 |
ローズ テクノロジーズ |
改良されたオキシコドン合成のための方法
|
AU2015207734B2
(en)
|
2014-01-15 |
2017-02-23 |
Rhodes Technologies |
Process for improved oxymorphone synthesis
|
US9062063B1
(en)
|
2014-03-21 |
2015-06-23 |
Johnson Matthey Public Limited Company |
Forms of oxymorphone hydrochloride
|
US9918979B2
(en)
|
2015-01-29 |
2018-03-20 |
Johnson Matthey Public Limited Company |
Process of preparing low ABUK oxymorphone hydrochloride
|
US9145420B1
(en)
|
2015-03-27 |
2015-09-29 |
Johnson Matthey Public Limited Company |
Crystalline forms of morphine sulfate
|
US10196355B2
(en)
|
2016-06-20 |
2019-02-05 |
Johnson Matthey Public Limited Company |
Forms of apremilast
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|